Andrew Le
Andrew Le is an American medical researcher.[1] He research and publishes his work on AI use in healthcare and brain cancer.[2]
Life and education[edit]
He was born in the United States to Vietnamese immigrants who escaped Vietnam by boat in 1979.[3] He attended Taylor High School, where he actively participated in charity work, raising funds for shelters after Hurricane Katrina.[4]
He pursued higher education at Harvard College, graduating magna cum laude and Phi Beta Kappa.[5] He then earned his doctorate of medicine from Harvard Medical School, specializing in neurosurgery.[6]
Career and research[edit]
During his medical training, he observed patients frequently resorting to online symptom searches, leading to misinformation and potential harm to their health.[7] While a third-year medical resident at Harvard Medical School in 2014, Le co-founded Buoy Health with his colleague Eddie Reyes.[8] He developed an AI-powered digital health tool that would function as a health-specific search engine, offering patients information and guidance.[1]
Le and his colleagues gathered enough data to educate the algorithm by hand-reading the 18,000-plus articles, then developing an algorithm to crunch the figures in real-time for everyone.[8]
He looked at 100 standardized cases with 33 varied diagnoses, ranging from a harmless cough to a potentially fatal pulmonary embolism, as well as the incidence of uncommon illnesses like histoplasmosis and the common cold.[7]
He has led Buoy through two successful investment rounds, raising over $67 million with healthcare investors like Optum, Cigna, Humana, and WR Hambrecht + Co, since establishing the firm out of Harvard Innovation Labs in 2014.[9]
Selected publications[edit]
- Le, Andrew; Reinshagen, Clemens; Redjal, Navid; Walcott, Brian P.; McDonnell, Erin; Dietrich, Jorg; Nahed, Brian V. (May 2016). "Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide". Journal of Neuro-Oncology. 127 (3): 505–514. doi:10.1007/s11060-016-2054-8.
- Le, Andrew; Tsimelzon, Anna; Long, Weiwen; Foulds, Charles E.; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W. (1 May 2010). "Research Resource: Expression Profiling Reveals Unexpected Targets and Functions of the Human Steroid Receptor RNA Activator (SRA) Gene". Molecular Endocrinology: 1090–1105. doi:10.1210/me.2009-0427. PMC 2870939.
- Le, Andrew; Walcott, Brian P.; Redjal, Navid; Coumans, Jean-Valery (October 2014). "Cervical osteophyte resulting in compression of the jugular foramen: Case report". Journal of Neurosurgery: Spine. 21 (4): 565–567. doi:10.3171/2014.6.SPINE13908.
- Le, Andrew; Barkauskas (August 2014). "Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function". Cell Stem Cell. 15 (2): 123–138. doi:10.1016/j.stem.2014.07.012.
References[edit]
- ^ a b Morrison, Jim. "Andrew Le's startup offers help to patients drowning in medical information". www.bizjournals.com.
- ^ Archambault, Joshua (21 April 2020). "Buoy Health – Intelligent Front Door to Optimized Healthcare | Podcast Hubwonk Latest News". Pioneer Institute.
- ^ "Top 25 Emerging leaders 2021". Modern Healthcare.
- ^ Martin, Betty L. "Valedictorian learned lessons from Rita". Chron.com. Houston Chronicle.
- ^ "Andrew Le - Co-Founder & CEO at Buoy Health". THE ORG.
- ^ Smith, Hallie (8 March 2017). "Wondering What Your Symptoms Mean? There's an App for That". Boston Magazine.
- ^ a b Ramsey Pflanzer, Lydia; Leonard, Kimberly. "Meet the 30 young leaders who are forging a new future for the $3.6 trillion healthcare industry". Business Insider.
- ^ a b Mack, Heather (8 March 2017). "Digital health startup Buoy launches AI-powered, symptom-checking chatbot". MobiHealthNews.
- ^ Bartlett, Jessica. "Buoy Health plans new hires, aims to reduce health care 'friction points'". www.bizjournals.com. Retrieved 2023-08-15.